Exelixis (EXEL) Other financing activities (2010 - 2026)

Exelixis' (EXEL) quarterly Other financing activities came in at $7.5 million in Q2 2026, down 35.74% year-on-year from $11.6 million in Q2 2025, and down 5.12% quarter-over-quarter from $7.9 million in Q1 2026.

Exelixis (EXEL) Other financing activities (2010 - 2026) Analysis & Trends

Exelixis' Other financing activities history runs 17 years deep, the most recent figure standing at $7.5 million for Q2 2026.

  • On a quarterly basis, Other financing activities fell 35.74% year-over-year to $7.5 million in Q2 2026; TTM through Apr 2026 was $45.0 million, a 30.97% decrease from a year earlier, with the FY2026 full-year figure at $49.1 million, down 20.55% from the prior year.
  • Other financing activities slipped to $7.5 million in Q2 2026 per EXEL's latest filing, from $7.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $26.1 million in Q3 2025 and bottomed at $2.9 million in Q3 2022.
  • The 5-year median for Other financing activities is $8.3 million (2024), against an average of $10.3 million.
  • Across the five-year window, Other financing activities jumped 186.09% in 2024 and tumbled 82.05% in 2025, its largest moves.
  • Year by year, Other financing activities stood at $5.2 million in 2022, then soared by 74.97% to $9.1 million in 2023, then soared by 117.25% to $19.8 million in 2024, then tumbled by 82.05% to $3.6 million in 2025, then soared by 110.36% to $7.5 million in 2026.
  • Per Business Quant, the three latest EXEL Other financing activities figures stand at $7.5 million (Q2 2026), $7.9 million (Q1 2026), and $3.6 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Exelixis 14.50 Bn 13.72 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 7.47 Mn
Apr 3, 2026 7.47 Mn
Jan 2, 2026 7.88 Mn
Jan 2, 2026 7.88 Mn
Oct 3, 2025 3.55 Mn
Oct 3, 2025 3.55 Mn
Jul 4, 2025 26.08 Mn
Jul 4, 2025 26.08 Mn
Apr 4, 2025 11.63 Mn
Apr 4, 2025 11.63 Mn
Jan 3, 2025 18.82 Mn
Jan 3, 2025 18.82 Mn
Sep 27, 2024 19.79 Mn
Sep 27, 2024 19.79 Mn
Jun 28, 2024 14.92 Mn
Jun 28, 2024 14.92 Mn
Mar 29, 2024 8.32 Mn
Mar 29, 2024 8.32 Mn
Dec 29, 2023 9.11 Mn
Dec 29, 2023 9.11 Mn